Noninfectious complications such as TRALI and TACO have become the leading risks associated
with allogeneic blood transfusions.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in AnesthesiaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Why an alternative to blood transfusion?.Crit Care Clin. 2009; 25 (Table): 261-277
- A new perspective on best transfusion practices.Blood Transfus. 2013; 11: 193-202
- Emerging pathogens—How safe is blood?.Transfus Med Hemother. 2014; 41: 10-17
- Transfusion-related acute lung injury.Eur J Anaesthesiol. 2014; 31: 345-350
- A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload.Transfus Med Rev. 2013; 27: 206-212
- Transfusion immunomodulation from a clinical perspective: an update.Expert Rev Hematol. 2013; 6: 653-663
- Clinical relevance of the HLA system in blood transfusion.Vox Sang. 2011; 101: 93-105
- Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.Br J Haematol. 2013; 160: 434-444
- Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.Transfusion. 2010; 50: 1144-1155
- Developments in the prevention of transfusion-associated graft-versus-host disease.Br J Haematol. 2012; 158: 563-568
- Identification of patients with postoperative complications who are at risk for failure to rescue.JAMA Surg. 2014; 149: 1103-1108
- Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes.Transfus Med Rev. 2011; 25: 232-246
- What is really dangerous: anaemia or transfusion?.Br J Anaesth. 2011; 107: i41-i59
- Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis.JAMA Intern Med. 2013; 173: 132-139
- SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents.Transfus Med. 2016; 26: 401-405
- Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies.Am Rev Respir Dis. 1983; 128: 185-189
- Transfusion-related acute lung injury: a review.Chest. 2004; 126: 249-258
- Perioperative transfusion-related acute lung injury: the Canadian Blood Services experience.Transfus Apher Sci. 2014; 50: 392-398
- The usefulness of a classification and regression tree algorithm for detecting perioperative transfusion-related pulmonary complications.Transfusion. 2015; 55: 2582-2589
- Transfusion-related acute lung injury: definition and review.Crit Care Med. 2005; 33: 721-726
- Proposed revised nomenclature for transfusion-related acute lung injury.Transfusion. 2017; 57: 709-713
- Understanding the consequences of transfusion-related acute lung injury.Chest. 2005; 128: 598S-604S
- Acute lung injury following blood transfusion: expanding the definition.Crit Care Med. 2008; 36: 3080-3084
- Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.J Clin Invest. 1998; 101: 1458-1467
- Transfusion-related acute lung injury: a change of perspective.Neth J Med. 2009; 67: 320-326
- Transfusion-related acute lung injury: three decades of progress but miles to go before we sleep.Transfusion. 2015; 55: 930-934
- Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.Transfusion. 2006; 46: 1478-1483
- The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study.Blood. 2011; 117: 4218-4225
- Transfusion-related acute lung injury: a clinical review.Lancet. 2013; 382: 984-994
- Transfusion-related acute lung injury: incidence and risk factors.Blood. 2012; 119: 1757-1767
- Characterizing the epidemiology of postoperative transfusion-related acute lung injury.Anesthesiology. 2015; 122: 12-20
- Epidemiology of acute lung injury.Curr Opin Crit Care. 2005; 11: 43-49
- Proceedings of a consensus conference: towards an understanding of TRALI.Transfus Med Rev. 2005; 19: 2-31
- Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury.Crit Care Clin. 2012; 28 (v): 363-372
- Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion.Cochrane Database Syst Rev. 2015; (CD009745)
- Transfusion-related acute lung injury: current concepts for the clinician.Anesth Analg. 2009; 108: 770-776
- Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.Br J Haematol. 2015; 170: 597-614
- Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: a systematic review.Crit Care Med. 2015; 43: 205-225
- Transfusion-related acute lung injured (TRALI): current concepts.Open Respir Med J. 2015; 9: 92-96
- Transfusion reactions and fatalities due to circulatory overloading.Br Med J. 1943; 2: 319-322
- Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study.Immunohematology. 1996; 12: 87-89
- N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload.Transfusion. 2008; 48: 1143-1150
- Breathlessness and blood: a combustible combination.Vox Sang. 2002; 83: 147-150
- How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention.Transfusion. 2013; 53: 3037-3047
- Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload.Curr Opin Hematol. 2007; 14: 682-687
- Adverse effects of plasma transfusion.Transfusion. 2012; 52: 65S-79S
- Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions.Transfusion. 2015; 55: 1838-1846
- Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients.Transfusion. 2011; 51: 338-343
- The prevention of transfusion-associated circulatory overload.Transfus Med Rev. 2013; 27: 105-112
Fatalities reported to FDA following blood collection and transfusion: annual summary for Fiscal Year 2012. US Food and Drug Administration. Last updated: March 28, 2014. Available at: https://www.fda.gov/biologicsbloodvaccines/safetyavailability/reportaproblem/transfusiondonationfatalities/ucm346639.htm. Accessed August 30, 2017.
- Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010.Transfusion. 2015; 55: 1223-1230
- Characterizing the epidemiology of perioperative transfusion-associated circulatory overload.Anesthesiology. 2015; 122: 21-28
- Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients.Chest. 2010; 137: 783-789
- Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis.BMJ. 2015; 350: h1354
What is Patient Blood Management? The Society for the Advancement of Blood Management (SABM). Available at: https://www.sabm.org/. Accessed August 30, 2017.
- Patient blood management as standard of care.Anesth Analg. 2016; 123: 1051-1053
- Blood transfusion therapy.Med Clin North Am. 2017; 101: 431-447
Article info
Footnotes
Conflicts of Interest: A. Shander has been a consultant or speaker with honorarium for or received research support from Bayer, Luitpold, Masimo, Novartis, Novo Nordisk, OrthoBiotech, Pfizer, and Zymogenetics; He is a founding member of the Society for the Advancement of Blood Management (SABM). M. Javidroozi has been a consultant and contractor for SABM and Gauss Surgical. T. Friedman and G. Lobel declare no relevant conflict of interests.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
